Anzeige
Mehr »
Login
Donnerstag, 16.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
190 Leser
Artikel bewerten:
(0)

PPJ Healthcare Enterprises, Inc. Announces New Medical Billing Client

Finanznachrichten News

TAMPA, FL / ACCESSWIRE / March 25, 2021 / PPJ Enterprise (Trading Symbol: OTC PINK:PPJE), a leader in Healthcare Reimbursement Cycle Expert for Complex Medical/Surgical Services and proprietary Automated Healthcare Practice Management Software, online Health Information Digital Systems and Medical Practice Information Management, is pleased to announce that the company signed new medical billing client.

To physicians and healthcare facilities: PPJE under Ms. Basu's management retain some of the highest ratings in the healthcare industry and remain at the cutting edge of healthcare reimbursement management especially for interventional pain management, anesthesia, surgery centers, LDL Apheresis, EMS fire and Emergency ambulance service and other complex specialties of medicine for the past 31 years.

"We can bring balance and success to any specialty of medicine, and help the practice become successful within a very short time, many billing services promise, we deliver." Ms. Basu noted.

As always, PPJE management advises shareholders, company followers and prospective investors to contact their financial advisors if they have any questions or concerns about their individual accounts and investment choices.

Regarding other news and events, the company reminds its followers to monitor OTC Markets filings tab for further newsworthy events and corporate updates, which will follow as they happen.

Forward-looking Statements

Information in this release may contain statements about future expectations, plans, prospects or performance of PPJ Enterprise that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project" and similar words and phrases are intended to identify such forward-looking statements. PPJ Healthcare Enterprises, Inc. cautions you that any forward-looking information provided by or on behalf of PPJ Healthcare Enterprises, Inc. is not a guarantee of future performance. None of the information in this press release constituted or is intended as an offer to sell securities or investment advice of any kind. PPJ Healthcare Enterprises, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond PPJ Healthcare Enterprises, Inc.'s control. In addition to those discusses in PPJ Healthcare Enterprises, Inc.'s press releases, public filings and statements by PPJ Healthcare Enterprises, Inc.'s management, including, but not limited to, PPJ Healthcare Enterprises, Inc.'s estimate of sufficiency of its existing capital resources, PPJ Healthcare Enterprises, Inc.'s ability to raise additional capital to fund future operations, PPJ Healthcare Enterprises, Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match PPJ Healthcare Enterprises, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. PPJ Healthcare Enterprises, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made to reflect the occurrence of unanticipated events.

For information please contact PPJ Healthcare Enterprises, Inc. 401 E. Jackson Street, Suite 2340, Tampa, FL 33602

Websites: https://www.ppjenterprise.com Email: info@ppjenterprise.com

SOURCE: PPJ Healthcare Enterprises, Inc.



View source version on accesswire.com:
https://www.accesswire.com/637401/PPJ-Healthcare-Enterprises-Inc-Announces-New-Medical-Billing-Client

© 2021 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.